Chinese pharmaceutical company WuXi AppTec plans to acquire US-based contract research organisation (CRO) ResearchPoint Global (RPG).

RPG will become WuXi AppTec’s wholly owned subsidiary following the completion of the acquisition.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The acquisition will help WuXi AppTec to strengthen its clinical research services worldwide.

“Chinese pharmaceutical company Cachet Pharmaceutical plans to acquire 51% stake in a Zhejiang-based biotechnology company for CNY43.8m ($6.65m).”

Chinese pharmaceutical company Cachet Pharmaceutical plans to acquire 51% stake in a Zhejiang-based biotechnology company for CNY43.8m ($6.65m).

Shenzhen Neptunus Bioengineering plans to acquire 10% stake in Shandong pharma company for CNY130m ($19.75m).

The Chinese pharmaceutical products manufacturer plans to pay the consideration in instalments through self-financing.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now